Services to CFOs

WithumSmith+Brown is well versed in the accounting and financial reporting requirements of our clients. We pride ourselves on quick responses to time sensitive requests. If the authoritative guidance is vague or off-point, we can participate in conferences with members of management, the auditors or the staff of the SEC's Chief Accountant. We also have in-depth knowledge of the CFO function and can augment their capabilities to address a myriad of tasks.

WS+B can deliver a wide range of attest and tax planning and compliance services including corporate governance and internal audit outsourcing. But a CFO (or principal financial officer) needs a great deal more.

For those involved with SEC Compliance and Reporting requirements, our experts can assist you with:

• Drafting financial statements and footnotes—in accordance with Regulation S-X
• Assisting in providing other SEC regulatory reporting, as required by Regulation S-X
• Assistance with 10K or 10Q preparation
• Review of financial information for compliance with required disclosures
• Drafting technical papers for your auditor
• Stock-based compensation calculations
• Goodwill and intangible asset valuations
• Tax provision and exposure analysis
• Compliance committee assistance
• Financial close process and guidance

The CFO has many other areas of responsibility and tasks where we can help, including:

• Domestic and international consolidations
• Dashboard development and reporting
• Best practices
• Audit preparation
• IFRS implementation
• "Carve-out/spin-out" accounting
• Business diagnostics
• Financing alternatives (debt & equity) and introductions
• Acquisition assistance
  • Planning/structure
  • Process management
  • Financing assistance
  • Due diligence
  • Purchase price allocation and valuation
  • Historical audits

Whatever challenges a CFO faces, WS+B is there to provide the effective and efficient support needed.

Examples of how WS+B has worked with CFOs:

• Audit services for a development-stage, medical device company in its final phase of regulatory approval before going public, including assistance with completion of a merger into a public shell
• Back-office support, including technical research and assistance with drafting of forms 10Q and 10K for a biopharmaceutical company
• Prepared annual financial statements of a development-stage pharmaceutical company for inclusion in an anticipated IPO
• Assistance with the conversion of historical Canadian-basis financial statements to U.S.- basis in preparation of a reverse acquisition into a public shell
• Back-year audits for target acquisition companies for a public company expanding through merger and acquisition
• Established "dashboard reporting" for a $100M family office with diverse operations
• Enhanced financial reporting and closing process for $1B public technology company